← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 21, 2024Last known activity
Dec 8, 2025
Timeline
2010s
- Jun 1, 2018
Satellos Bioscience— Founded
2020s
- Mar 22, 2021
iCo Therapeutics Inc.— Acquired
Drugs by trial phase (3 distinct, 5 trials)
Phase 2 (1 own, 2 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (4)
- NCT07287189Lead sponsorPhase 2Dec 8, 2025
- NCT07287189OfficialPhase 2Dec 8, 2025
- NCT06867107Lead sponsorPhase 2May 1, 2025
- NCT06565208Lead sponsorEarly Phase 1Aug 21, 2024
Details
- Founded
- Toronto, CA Jun 1, 2018
- Last known activity
- Dec 8, 2025